Special Considerations for the Use of P13K Inhibitors Flashcards
1
Q
Duvelisib Dosing
A
25 mg PO twice daily
2
Q
Idelalisib Dosing
A
150 mg PO twice daily
Chronic Lymphocytic Leukemia > Special Considerations for the Use of P13K Inhibitors > Flashcards
Duvelisib Dosing
25 mg PO twice daily
Idelalisib Dosing
150 mg PO twice daily